Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/5/25 20:00 | 3/3/25 | JANX | Health | Drug | Pharmaceutical Preparations | Meyer Andrew Hollman | CA | O | Chief Bu | 4 | S.d | -3,278 | 46.82 | 0 | -70 | 82 | D | |||||||||||||||
1/8/25 20:00 | 1/7/25 | JANX | Health | Drug | Pharmaceutical Preparations | Campbell David Alan | CA | DO | P,CEO | 6 | S | -6,496 | 54.13 | 0 | -120 | 307 | D | |||||||||||||||
10/24/24 16:15 | 9/13/24 | JANX | Health | Drug | Pharmaceutical Preparations | Lichter Jay | CA | T | 2 | S.d | -82,303 | 54.73 | 0 | -1,504 | 7,249 | D | ||||||||||||||||
10/18/24 18:51 | 10/16/24 | JANX | Health | Drug | Pharmaceutical Preparations | Avalon Ventures Xi, L.P. | CA | T | 5 | S.dm | -205,376 | 49.20 | 0 | -4,174 | 9,779 | M | ||||||||||||||||
9/27/24 19:31 | 9/27/24 | JANX | Health | Drug | Pharmaceutical Preparations | Diraimondo Thomas | CA | O | Chief Sc | 1 | S | -232 | 46.34 | 0 | -5 | 98 | D | |||||||||||||||
6/5/24 19:23 | 6/3/24 | JANX | Health | Drug | Pharmaceutical Preparations | Reardon Tighe | CA | O | Acting C | 1 | S | -45,044 | 54.75 | 0 | -823 | 4,149 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |